Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,759 | 419 | 88.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $800.00 | 1 | 8.0% |
| Education | $383.78 | 6 | 3.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Incyte Corporation | $1,464 | 28 | $0 (2024) |
| ABBVIE INC. | $1,380 | 74 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $892.34 | 38 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $867.81 | 22 | $0 (2024) |
| Lilly USA, LLC | $795.42 | 39 | $0 (2024) |
| Janssen Biotech, Inc. | $743.19 | 35 | $0 (2024) |
| Dermavant Sciences, Inc. | $663.66 | 29 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $525.54 | 36 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $463.15 | 28 | $0 (2024) |
| GENZYME CORPORATION | $426.46 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,825 | 133 | Incyte Corporation ($1,106) |
| 2023 | $2,501 | 126 | Dermavant Sciences, Inc. ($347.49) |
| 2022 | $2,009 | 91 | ABBVIE INC. ($499.45) |
| 2021 | $1,608 | 76 | Regeneron Healthcare Solutions, Inc. ($260.45) |
All Payment Transactions
426 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: Immunology | ||||||
| 12/18/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: Immunology | ||||||
| 12/13/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $26.36 | General |
| Category: Dermatology | ||||||
| 12/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $10.58 | General |
| Category: Immunology | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $28.04 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.97 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $10.54 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Incyte Corporation | OPZELURA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $800.00 | General |
| Category: Dermatology | ||||||
| 12/05/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $39.76 | General |
| Category: Immunology | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: Immunology | ||||||
| 11/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.16 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $107.95 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $79.99 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Kerecis Limited | Kerecis Omega3 SurgiClose (Device), Kerecis Omega3 Marigen, Kerecis Omega3 Marigen | Food and Beverage | Cash or cash equivalent | $27.02 | General |
| Category: Wound Care | ||||||
| 11/12/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $26.87 | General |
| Category: Dermatology | ||||||
| 10/30/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: Immunology | ||||||
| 10/29/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $24.47 | General |
| Category: DERMATOLOGY | ||||||
| 10/29/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $11.59 | General |
| Category: DERMATOLOGY | ||||||
| 10/29/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $4.33 | General |
| Category: DERMATOLOGY | ||||||
| 10/24/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $7.49 | General |
| Category: Immunology | ||||||
| 10/23/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $21.90 | General |
| 10/22/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $27.95 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 2,011 | 8,877 | $478,831 | $124,900 |
| 2022 | 13 | 1,821 | 3,160 | $405,681 | $102,172 |
| 2021 | 12 | 1,629 | 2,723 | $353,722 | $92,372 |
| 2020 | 11 | 1,199 | 1,953 | $253,861 | $59,085 |
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 503 | 782 | $126,684 | $37,673 | 29.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 241 | 304 | $73,568 | $18,621 | 25.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 332 | 494 | $70,148 | $14,309 | 20.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 236 | 274 | $59,458 | $13,412 | 22.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 109 | 147 | $34,398 | $9,872 | 28.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 146 | 146 | $34,018 | $8,389 | 24.7% |
| J7345 | Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | Office | 2023 | 23 | 5,400 | $21,600 | $7,010 | 32.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 204 | 1,079 | $14,027 | $4,163 | 29.7% |
| 96574 | Application of light with debridement to destroy precancer skin growth | Office | 2023 | 16 | 19 | $10,830 | $2,976 | 27.5% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 60 | 81 | $9,396 | $2,321 | 24.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 73 | 80 | $7,920 | $2,183 | 27.6% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 25 | 28 | $7,924 | $1,979 | 25.0% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 11 | 11 | $2,992 | $799.29 | 26.7% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 20 | 20 | $3,300 | $679.80 | 20.6% |
| 69100 | Biopsy of ear | Office | 2023 | 12 | 12 | $2,568 | $512.62 | 20.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 440 | 658 | $106,596 | $30,588 | 28.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 233 | 314 | $75,988 | $19,041 | 25.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 298 | 454 | $64,468 | $12,945 | 20.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 206 | 237 | $51,429 | $11,444 | 22.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 78 | 104 | $24,336 | $7,268 | 29.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 134 | 134 | $31,222 | $7,077 | 22.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 199 | 1,003 | $13,039 | $3,778 | 29.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 112 | 122 | $12,078 | $3,586 | 29.7% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2022 | 25 | 30 | $8,490 | $2,054 | 24.2% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 19 | 21 | $5,712 | $1,681 | 29.4% |
About Melanie Haney, NP
Melanie Haney, NP is a Family healthcare provider based in Portage, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/29/2007. The National Provider Identifier (NPI) number assigned to this provider is 1851437859.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Melanie Haney, NP has received a total of $9,943 in payments from pharmaceutical and medical device companies, with $3,825 received in 2024. These payments were reported across 426 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($8,759).
As a Medicare-enrolled provider, Haney has provided services to 6,660 Medicare beneficiaries, totaling 16,713 services with total Medicare billing of $378,529. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Portage, IN
- Active Since 01/29/2007
- Last Updated 07/08/2007
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1851437859
Products in Payments
- OPZELURA (Drug) $1,451
- DUPIXENT (Biological) $1,354
- TREMFYA (Drug) $726.30
- TALTZ (Drug) $717.97
- VTAMA (Drug) $663.66
- SKYRIZI (Biological) $636.44
- RINVOQ (Biological) $592.95
- Sotyktu (Drug) $520.18
- COSENTYX (Biological) $294.24
- ADBRY (Biological) $267.14
- COSENTYX (Drug) $253.33
- Winlevi (Drug) $204.65
- Bimzelx (Biological) $201.63
- ILUMYA (Biological) $200.16
- Cimzia (Drug) $150.89
- REMICADE (Biological) $141.89
- EBGLYSS (Drug) $77.45
- HUMIRA (Biological) $74.89
- ENSTILAR (Drug) $72.65
- CLODERM (Drug) $68.74
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Portage
Robin Anderson, Np-C, NP-C
Family — Payments: $262,159
Mrs. Sandra Scholebo, Rn, Msn, Fnp, RN, MSN, FNP
Family — Payments: $7,899
Katrina Kozub, Fnp, FNP
Family — Payments: $6,312
Megan Lawrence
Family — Payments: $5,707
Marlee Pratt, Fnp, FNP
Family — Payments: $3,835
Carolyn Blouir, Fnp-C, FNP-C
Family — Payments: $3,826